Curaleaf's Boris Jordan on CBD regulation and second-quarter earnings

Curaleaf executive chairman Boris Jordan discusses the company's second quarter results as well as CBD regulation from the FDA with CNBC's "Squawk on the Street".

Squawk on the Street,CNBC,business news,finance stock,stock market,news channel,news station,breaking news,us news,world news,cable,cable news,finance news,money,money tips,financial news,stock market news,stocks,